Indian Markets Edge Higher; Key Corporate Developments Across Sectors
Indian stock markets closed marginally higher as investors reacted to GST reforms. The Nifty index gained 4%, with 23 Indian stocks becoming multibaggers. Zydus Lifesciences entered the US multiple sclerosis market through a partnership with Synthon BV. NTPC discontinued its 440-MW Tanda thermal project. Several companies announced strategic partnerships and operational changes, including Varun Beverages, Torrent Pharma, and Bharat Forge. Banking and financial services updates included new branches for Karur Vysya Bank and HDFC Life's expectations on GST reforms. Regulatory news involved Biocon receiving FDA observations and the GST Council announcing rate cuts.

*this image is generated using AI for illustrative purposes only.
Indian stock markets closed marginally higher as investors reacted to developments in GST reforms. Meanwhile, several companies made significant announcements, ranging from strategic partnerships to operational changes. The Nifty index gained 4%, while 23 Indian stocks became multibaggers with exceptional returns.
Market Performance
While the broader market showed modest gains, some stocks delivered extraordinary returns:
Company | Price Change | Percentage Gain |
---|---|---|
Elitecon International | Rs 10 to Rs 281 | 2,667.00% |
RRP Semiconductor | - | 2,611.00% |
Midwest Gold | - | 1,716.00% |
GHV Infra Projects | - | 1,435.00% |
String Metaverse | - | 742.00% |
Blue Pearl Agriventures | - | 719.00% |
The auto ancillary sector produced 6 multibaggers, while Apollo Micro Systems doubled in the defence sector.
Foreign investors withdrew over Rs 1.5 lakh crore amid global trade tensions and tariff policies. Market experts remain divided on future prospects, with some expecting Nifty to reach new highs driven by BFSI, autos, and consumer discretionary sectors, while others warn of delayed impacts from trade tensions.
Zydus Lifesciences Enters US Market with MS Drug Partnership
Zydus Lifesciences Ltd. has announced a strategic move into the US multiple sclerosis treatment market. The company's wholly-owned subsidiary, Zydus Lifesciences Global FZE, has entered into an exclusive licensing and supply agreement with Netherlands-based Synthon BV for Ozanimod Capsules, a generic version of ZEPOSIA®.
Key points of the agreement:
- Synthon will handle regulatory approval, manufacturing, and supply
- Zydus will be responsible for commercialization in the USA
- Synthon has received tentative approval from the U.S. FDA, making the product eligible for a shared 180-day exclusivity upon market entry
Punit Patel, President and CEO of Zydus Pharmaceuticals (USA) Inc., stated, "This collaboration with Synthon enables us to bring this important treatment to the U.S. market. This collaboration reinforces our strategic focus on advancing care in therapeutic areas and reflects our commitment to making essential medicines more accessible to patients."
The total addressable market opportunity for Ozanimod Capsules in the U.S. is approximately $637.00 million, according to IQVIA MAT data.
NTPC Discontinues Tanda Thermal Project
NTPC Ltd. announced the permanent discontinuation of its 440-MW Stage-I Tanda thermal project in Uttar Pradesh, effective September 1. This move is likely part of NTPC's ongoing efforts to optimize its power generation portfolio.
Corporate Developments and Partnerships
- Varun Beverages incorporated a joint venture company, White Peak Refrigeration Pvt., to manufacture visi-coolers and refrigeration equipment.
- Torrent Pharma will acquire a 26% stake in JB Chemicals for Rs 6,843.00 crore at Rs 1,639.18 per share.
- Bharat Forge's arm purchased 949.65 acres in Andhra Pradesh for a defense energetics manufacturing complex.
- Trent's arm incorporated a new wholly owned subsidiary for real estate investments.
- Rail Vikas Nigam Ltd. and Texmaco Rail agreed to incorporate a new company by November as part of their joint venture agreement.
Banking and Financial Services Updates
- Karur Vysya Bank will open three new branches and reduced its lending rates.
- HDFC Life expects GST reforms to boost demand and its value of new business with minimal impact on embedded value (less than 0.50%).
- UTI AMC appointed Vetri Subramaniam as managing director and CEO.
Regulatory and Industry News
- Biocon received a Form 483 with five observations from the US FDA following an inspection at its Bengaluru plant.
- Travel Food Services signed a lounge services agreement with Dreamfolks Services.
- Reliance Retail plans to pass lower GST rate benefits to consumers.
- The GST Council announced rate cuts across insurance, medicines, and essential goods to stimulate consumption.
Other Corporate Announcements
- TVS Motor Company introduced the TVS NTORQ 150, positioning it as India's first hyper sport scooter targeting Gen Z riders.
- Sammaan Capital appointed Himanshu Mody as Deputy CEO, effective September 4.
As the Indian market continues to evolve, these corporate developments reflect the dynamic nature of various sectors, from pharmaceuticals and power to manufacturing and consumer goods.